Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs13343502 | chr19:37962292 | C/T | 1.76E-13 | 133 | 45.47 | 36.12 | 17.1 | KM Plot |
| TGCT | rs13357047 | chr5:88210655 | A/G | 7.84E-7 | 134 | 0.57 | 69.63 | 41.97 | KM Plot |
| TGCT | rs13387476 | chr2:54762985 | C/T | 0.000156 | 131 | 46.3 | 46.3 | 18.57 | KM Plot |
| TGCT | rs1359537 | chr13:79213552 | C/T | 9.12E-5 | 127 | 45.1 | 25.77 | 87.03 | KM Plot |
| TGCT | rs138157795 | chr7:156580637 | A/C | 0.000126 | 129 | 44.05 | 68.97 | 32.85 | KM Plot |
| TGCT | rs138192317 | chr10:27588549 | G/A | 0 | 127 | 42.18 | 45.83 | 18.85 | KM Plot |
| TGCT | rs138354053 | chr14:78184281 | T/TC | 7.4E-5 | 134 | 45.1 | 39.38 | 18.07 | KM Plot |
| TGCT | rs1385374 | chr12:129300694 | C/T | 1.39E-5 | 134 | 41.33 | 44.28 | 29.53 | KM Plot |
| TGCT | rs138675549 | chr16:74207299 | AAATT/A | 0.000167 | 128 | 46.3 | 36.97 | 57.87 | KM Plot |
| TGCT | rs138896076 | chr6:8400325 | TA/TAA | 0.000127 | 131 | 42.1 | 46.3 | 17.1 | KM Plot |
| TGCT | rs138946835 | chr8:116906250 | CATA/C | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs139277547 | chr10:27589507 | G/A | 0 | 127 | 42.18 | 45.83 | 18.85 | KM Plot |
| TGCT | rs139301947 | chr16:67584362 | C/G | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |
| TGCT | rs139554544 | chr6:15223291 | A/G | 7.25E-5 | 131 | 37.62 | 45.1 | NA | KM Plot |
| TGCT | rs139602953 | chr20:58139972 | GAGAC/G | 2.79E-13 | 131 | 39.38 | 79.62 | 17.1 | KM Plot |